Research Articles
Science-backed guides on research peptides available in Australia. For laboratory and research use only.
47 articles
Retatrutide Australia 2026: Research Guide, Dosage, Cost & Where to Buy
Retatrutide (LY3437943) is a triple-receptor agonist (GLP-1, GIP, glucagon) that produced 24.2% mean weight loss in Phase 2 trials, the largest reported in any pharmacological trial to date. This guide covers 2026 TRIUMPH trial status, monthly cost estimates, dosage, reconstitution, and where to source research-grade Retatrutide in Australia.
BPC-157 Research Guide: Mechanism, Angiogenesis & Tissue-Repair Data (Australia)
BPC-157 is a stable pentadecapeptide derived from a protein in gastric juice, and one of the most-studied research peptides for tissue repair. This monograph covers what it is, how it works (angiogenesis via VEGF and the nitric-oxide system), and the tendon, ligament, bone and gut preclinical evidence base.
Retatrutide vs Tirzepatide: Which Triple Agonist Leads Metabolic Research?
Retatrutide and tirzepatide are both next-generation metabolic research compounds, but their receptor profiles differ in one crucial way. This comparison breaks down the mechanisms, clinical data, and research implications.
How to Reconstitute Research Peptides: Step-by-Step Guide
All research peptides from OzPeps are supplied as lyophilised (freeze-dried) powder. This guide covers exactly how to reconstitute them safely, calculate concentrations, and store reconstituted solutions correctly.
Selank in Australia: Nootropic Research Guide & Where to Buy
Selank is a synthetic heptapeptide analogue of tuftsin with documented anxiolytic and nootropic properties in preclinical and clinical research. Developed by the Institute of Molecular Genetics in Russia, it has an unusually robust research base for a peptide of its class.
Semax in Australia: Nootropic & Neuroprotective Research Guide
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence with potent nootropic and neuroprotective properties. Clinically approved in Russia for stroke recovery and cognitive impairment, it remains one of the best-documented peptide nootropics available.
MOTS-c: The Mitochondrial-Encoded Peptide That Activates AMPK (Australia Research Guide)
MOTS-c is a 16-amino-acid peptide encoded inside mitochondrial DNA (the 12S rRNA gene), not the nucleus, which makes it mechanistically unlike any other research peptide. It activates AMPK by disrupting the one-carbon folate cycle, driving glucose uptake and fat oxidation. This guide covers its mtDNA origin, the folate→AMPK mechanism, the key insulin-sensitivity and exercise-metabolism studies, and how it differs from the other major mitochondrial peptide, SS-31.
CJC-1295 & Ipamorelin Australia 2026: Research Guide, Dosing & Where to Buy
CJC-1295 and Ipamorelin are complementary growth hormone secretagogues studied in combination for synergistic pulsatile GH release. CJC-1295 mimics GHRH (extending GH signal duration); Ipamorelin selectively activates the ghrelin receptor pathway. Together they produce GH pulses 2–10× greater than either compound alone. This guide covers mechanism, Phase 2 clinical data, dosing protocols, reconstitution, and where to buy in Australia.
PT-141 (Bremelanotide): the MC4R Sexual-Function Research Peptide (Australia Guide)
PT-141 (Bremelanotide) is the MC4R-selective melanocortin agonist that became Vyleesi, the only melanocortin compound to win FDA approval (2019, for hypoactive sexual desire disorder in premenopausal women). Unlike PDE5 inhibitors, it acts centrally in the hypothalamus on sexual-motivation circuits, making it a distinct research tool for studying CNS melanocortin pathways.
GHK-Cu Copper Peptide Australia: Copper-Binding & the 4,072-Gene Effect (Research Guide)
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a copper-binding tripeptide whose biology is driven by an exceptionally high copper affinity (log K ≈ 16.44) and an unusually broad transcriptional footprint, modulating 4,072 genes in human fibroblasts. This guide explains the copper-binding chemistry, SOD-like antioxidant and biphasic MMP/ECM-remodelling mechanisms, and the gene-expression dataset that distinguishes GHK-Cu from targeted peptides.
TB-500 (Thymosin Beta-4) Australia 2026: Research Guide, Dosing & Where to Buy
TB-500 is a synthetic analogue of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found in virtually every mammalian cell and one of the most abundant intracellular proteins in platelets and wound fluid. It is studied extensively for tissue repair, cell migration, angiogenesis, cardiac protection, and anti-inflammatory activity. This guide covers mechanism, research findings, dosing protocols, reconstitution, and where to buy research-grade TB-500 in Australia.
Melanotan II in Australia: Research Guide & Where to Buy
Melanotan II (MT-2) is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) with broad melanocortin receptor activity. Originally developed at the University of Arizona in the 1980s, it remains one of the most studied melanocortin research compounds available.
Epitalon (Epithalan) in Australia: Longevity Research Guide
Epithalan (also Epitalon, tetrapeptide Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the pineal gland extract Epithalamin, developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation. It is one of the most studied longevity peptides in the Russian biogerontology literature, with research spanning telomerase activation, circadian rhythm regulation, and lifespan extension in multiple animal models.
DSIP in Australia: Delta Sleep-Inducing Peptide Research Guide & Where to Buy
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide that has been studied for its effects on sleep architecture, stress response, and neuroendocrine regulation. This guide covers the research evidence, mechanism of action, vial sizes, and where to source DSIP in Australia.
NAD+ Peptides vs NAD+ Precursors: A Research Comparison for Australian Researchers
NAD+ (nicotinamide adenine dinucleotide) sits at the centre of cellular energy metabolism and has become one of the most studied molecules in ageing research. This guide compares direct NAD+ supplementation with NAD+ precursors, NMN and NR, from a research perspective.
Peptides for Recovery Research: BPC-157, TB-500 and MOTS-c
BPC-157, TB-500, and MOTS-c represent three distinct mechanistic approaches to recovery-related research. Each targets different biological pathways, from local tissue repair to mitochondrial biogenesis, making them complementary subjects for preclinical investigation.
Nootropic Peptides in Australia: Semax, Selank and Cognitive Research
Nootropic peptides represent one of the most active areas of neuroscience research. Semax and Selank, two Russian-developed synthetic peptides, have the most substantial research profiles for cognitive and neurological applications among compounds available from Australian research suppliers.
Selank and Semax: Russian Clinical Trial Evidence: A Research Synthesis
Selank and Semax are synthetic heptapeptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Unlike most research peptides, both have a published clinical trial history, arising from the Soviet and post-Soviet neuropsychiatric research tradition that produced extensive peptide pharmacology data largely inaccessible to non-Russian researchers. This article synthesises that evidence base: what the trials found, what the mechanisms are, where the evidence is strong, and where it has limitations.
GLP-1 Peptide Research in Australia: Tirzepatide, Retatrutide & Semaglutide
GLP-1 receptor agonists have become the most consequential class of metabolic research compounds of the past decade. This guide covers the science behind GLP-1, how next-generation dual and triple agonists like Tirzepatide and Retatrutide differ, and where to source them for research in Australia.
Tesamorelin in Australia: Research Guide & Where to Buy
Tesamorelin is a synthetic 44-amino acid GHRH analogue with FDA approval for HIV-associated lipodystrophy, one of the few research peptides to have completed Phase 3 clinical trials. This guide covers the mechanism, clinical research data, comparison with other GHRH analogues, and where to source research-grade Tesamorelin in Australia.
BPC-157 & TB-500 Oral Tablets Australia: Do They Work vs Injectable?
Oral BPC-157 and TB-500 tablets are increasingly marketed as needle-free alternatives to injectable peptides. This guide examines what the preclinical research actually shows about bioavailability and delivery method, and what that means for researchers sourcing these compounds in Australia.
IGF-1 LR3 in Australia: Research Guide, Mechanism & Where to Buy
IGF-1 LR3 is a synthetic, long-acting analogue of insulin-like growth factor 1 with an extended half-life that makes it a key tool in growth factor research. This guide covers the mechanism, differences from native IGF-1, research applications, and where to source it in Australia.
5-Amino-1MQ in Australia: NNMT Inhibitor Research Guide
5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor generating significant research interest for its effects on adipocyte metabolism and energy expenditure. This guide covers the mechanism, research landscape, and how it differs from GLP-1-based compounds like retatrutide.
HCG in Australia: Research Guide, Vial Sizes & Where to Buy
HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone that mimics LH (luteinising hormone), making it a key tool in HPG axis and reproductive biology research. This guide covers the mechanism, research applications, vial sizes, and where to source research-grade HCG in Australia.
KLOW Blend in Australia: BPC-157, TB-500, GHK-Cu & KPV Research Guide
The KLOW blend combines four research peptides (BPC-157, TB-500, GHK-Cu, and KPV) in a single lyophilised vial. Each compound has an independent mechanism of action; together they represent complementary pathways in tissue repair, inflammation modulation, and cellular regeneration research.
GHK-Cu for Hair Growth: What the Research Shows (Australia)
GHK-Cu (Glycine-Histidine-Lysine copper complex) has emerged as one of the most researched peptides in hair follicle biology. This guide covers the mechanisms behind its effects on follicle size, anagen phase duration, and angiogenesis, and what the research actually shows.
How to Set Up a Crypto Wallet in Australia to Buy Online (2026 Beginner's Guide)
Buying online with cryptocurrency is easier than most people think. This guide covers the two main ways Australians can get set up (Exodus wallet for the fastest start, or an exchange for the best rates) plus how to pay with Monero when most exchanges have delisted it.
GLOW 70 Blend in Australia: BPC-157, GHK-Cu & TB-500 Research Guide
GLOW 70 combines three established research peptides (BPC-157, GHK-Cu, and TB-500) in a single lyophilised 70mg vial. Each compound targets a distinct biological pathway; together they represent complementary mechanisms in tissue repair, connective tissue remodelling, and inflammation research.
Retatrutide Price in Australia: What Does It Cost?
Retatrutide is one of the most researched next-generation triple agonist peptides available in Australia. This guide covers what research-grade Retatrutide costs by vial size, what drives price differences between suppliers, and what to look for when sourcing.
HGH vs Peptide Secretagogues: CJC-1295, Ipamorelin & Tesamorelin Research Guide
Exogenous HGH and peptide secretagogues like CJC-1295, Ipamorelin, and Tesamorelin both elevate growth hormone signalling, but through fundamentally different mechanisms. This research guide compares their pharmacology, published data, stability profiles, and reconstitution requirements.
Semaglutide vs Tirzepatide vs Retatrutide: Full GLP-1 Class Comparison (Australia)
Semaglutide, Tirzepatide, and Retatrutide represent three generations of GLP-1-class research compounds, from single to dual to triple receptor agonism. This guide compares their receptor targets, published clinical data, weight-loss outcomes, and research applications for Australian researchers.
Semaglutide in Australia: GLP-1 Research Guide
Semaglutide is a GLP-1 receptor agonist that revolutionised metabolic and weight regulation research. This guide covers its mechanism, clinical trial data, and how it sits in the broader GLP-1 research landscape alongside tirzepatide and retatrutide.
Research HGH: IU vs mg, Vial Sizes & Reconstitution Math
Research HGH (somatropin) is dosed in International Units (IU), not milligrams, which makes vial labels and reconstitution math confusing. This guide explains the IU↔mg relationship, what OzPeps’ 10IU, 24IU and 40IU vial presentations actually mean, and how to calculate the bacteriostatic water volume for a target concentration. Research use only.
Are Research Peptides Legal in Australia? 2026 Guide
The legal status of research peptides in Australia depends on TGA scheduling, intended use, and how they are supplied. This guide covers what researchers need to know about the regulatory landscape in 2026.
Longevity Peptides in Australia: Research Guide 2026
Longevity research has moved from descriptive biology to targeted intervention. This guide covers the major peptide and small-molecule compounds studied for hallmarks of ageing (Epitalon, MOTS-c, SS-31, GHK-Cu, and NAD+) and what is available for research in Australia.
How to Buy Research Peptides with Crypto in Australia
OzPeps accepts Litecoin (LTC), Monero (XMR), and Bitcoin (BTC) for all research peptide orders. This guide explains why crypto is well-suited for research compound purchases, how each coin compares, and how to complete a payment step-by-step.
Semax vs Selank in Australia: Research Comparison
Semax and Selank are both developed at the Institute of Molecular Genetics in Moscow, and both studied for neuroprotection and cognitive effects, but they target distinct mechanisms. This guide compares the two compounds for Australian researchers.
Research Peptide Safety & Side Effects: What the Science Says (Australia 2026)
Following renewed Australian media coverage of research peptides, this guide consolidates what the published science actually says about safety profiles, commonly observed effects in studies, and risk factors across peptide categories, from GLP-1 receptor agonists to structural repair peptides.
Research Peptides in Australia: Complete Guide (2026)
A comprehensive reference guide to research peptides in Australia, covering categories, mechanisms, TGA legal context, sourcing quality indicators, reconstitution, and the most actively studied compounds available from Australian suppliers in 2026.
SLU-PP-332 Australia: Exercise Mimetic Research Compound Guide
SLU-PP-332 is a small-molecule ERRα (Estrogen-Related Receptor alpha) agonist that activates the transcriptional programme of endurance exercise in skeletal muscle without physical activity. A 2023 Nature Communications study demonstrated a 70% improvement in treadmill endurance in sedentary mice over four weeks. This guide covers the mechanism, published research, and context for Australian researchers.
Crypto Payments for Peptide Orders in Australia: A Researcher's Guide
Australian research laboratories working with research-grade peptides increasingly use cryptocurrency payments to overcome banking barriers, protect order privacy, and ensure supply-chain continuity. This guide covers accepted tokens, step-by-step checkout, and 2026 best practices.
The Science of GLP-1 Receptor Agonists in Weight Loss Research
GLP-1 receptor agonists are central to metabolic and obesity research, with agents like Retatrutide, Tirzepatide, and Semaglutide showing substantial weight reduction in controlled trials. This guide covers receptor pharmacology, clinical efficacy, laboratory protocols, emerging agents, and Australian research-grade sourcing.
TB-500 vs BPC-157: How the Two Repair Peptides Differ (Australia Research Guide)
TB-500 and BPC-157 are the two most-studied tissue-repair research peptides, but they are not interchangeable: one is a 43-residue actin-regulating fragment of an endogenous protein, the other a 15-residue gastric-derived pentadecapeptide, and they engage different mechanisms (systemic cell migration vs local VEGF-driven angiogenesis). This guide compares them head-to-head (origin and class, mechanism, molecular size, research focus and research status) and sets out how a researcher chooses between them for a given study context. It is a decision/comparison guide, not a monograph or a stack page.
Ipamorelin vs CJC-1295: How These Two GH-Axis Peptides Differ (Australia Research Guide)
Ipamorelin and CJC-1295 both raise growth hormone, but by different mechanisms: Ipamorelin is a selective GHRP / ghrelin-receptor (GHSR-1a) agonist that triggers sharp, pulsatile GH release with minimal cortisol or prolactin effect, while CJC-1295 is a GHRH analogue that raises baseline GH and IGF-1, over ~30 minutes (no-DAC) or ~6–8 days (with DAC). This guide compares the two head-to-head (class, receptor, mechanism, half-life, selectivity) and explains which a researcher would choose for a given model. It does NOT cover combining them; for that, see the combination research guide.
MOTS-c Molecular Profile: Sequence, Structure, Molecular Weight & Mechanism
A structural and biochemical reference for MOTS-c: the 16-amino-acid sequence MRWQEMGYIFYPRKLR, its ~2174.6 Da molecular weight, the unusual mitochondrial 12S rRNA gene that encodes it, and the molecular-level AMPK mechanism (folate-cycle inhibition → AICAR/ZMP accumulation → allosteric AMPK activation) plus nuclear translocation. Covers what is and is not known about its pharmacokinetics, and a 10mg-vial reconstitution-math worked example. Research-use only.
SS-31 (Elamipretide) Molecular Profile: Structure, Cardiolipin Binding & Mechanism
SS-31 (better known by its development names elamipretide, MTP-131 and Bendavia) is a synthetic aromatic-cationic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that concentrates in the inner mitochondrial membrane and binds the phospholipid cardiolipin. This molecular profile covers its exact structure, molecular weight and class, the cardiolipin-binding mechanism that stabilises cristae and supports electron transport, and the verified elamipretide clinical-research record, including its 2025 first-in-class approval for Barth syndrome.
TB-500 Reconstitution Protocol: Concentration Math & Volume Calculator
A TB-500-specific reconstitution reference: exactly how much bacteriostatic water to add to a 10mg vial, the resulting mg/mL concentration table, insulin-unit (U-100) conversions, and worked arithmetic for measuring any target research quantity. This page is the math, not the biology, for the full TB-500 research overview and for generic reconstitution steps it defers to the dedicated guides.